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We have analyzed the off-target activity of two siRNAs (F7-1, F7-2) that knock-down human blood coagulation factor 7
mRNA. F7-1 modulates a significant number of non-target transcripts while F7-2 shows high selectivity for the target
transcript under various experimental conditions. The 3’-UTRs of all F7-1 off-target genes show statistically significant
enrichment of the reverse complement of the F7-1 siRNA seed region located in the guide strand. Seed region
enrichment was confirmed in off-target transcripts modulated by siRNA targeting the glucocorticoid receptor. To
investigate how these sites contribute to off-target recognition of F7-1, we employed CXCL5 transcript as model system
because it contains five F7-1 seed sequence motifs with single base mismatches. We show by transient transfection of
reporter gene constructs into HEK293 cells that three out of five sites located in the 3’-UTR region are required for F7-1
off-target activity. For further mechanistic dissection, the sequences of these sites were synthesized and inserted either
individually or joined in dimeric or trimeric constructs. Only the fusion constructs were silenced by F7-1 while the
individual sites had no off-target activity. Based on F7-1 as a model, a single mismatch between the siRNA seed region
and mRNA target sites is tolerated for target recognition and the CXCL5 data suggest a requirement for binding to
multiple target sites in off-target transcripts.
Introduction
RNA interference (RNAi) is a naturally occurring mechanism in
higher eukaryotes that degrades foreign RNA introduced by viral
invaders and other pathogens. The RNAi machinery is well-
conserved from plants to animals and allows in mammalian cells
not only cell defense mechanisms but also endogenous micro-
RNAs (miRNAs) controlled gene regulation. miRNAs are short
intracellular RNA duplexes that bind in a sequence-dependent
manner to target transcripts, resulting in reduced transcript
abundance either by Ago-2 dependent mRNA degradation or
by mRNA destabilization.
1 Shortly after discovery of the RNAi
mechanism in nematodes by Fire et al.,
2 Elbashir et al.
3 demon-
strated that transfection of short double-stranded RNAs (siRNAs)
can trigger in mammalian cells RNAi-mediated decay of specific
transcripts. This mechanism, also known as exogenous RNAi
pathway, has led siRNA to become an indispensable and valuable
research tool for functional genomics in cell lines and rodent
animal models.
4
Based onthepossibility of targetingthetranscriptofvirtually any
gene in the cell, significant interest in exploring RNAi as a novel
treatment modality for human diseases was elicited.
5,6 However,
this approach suffers from a lack of efficient and specific delivery
vehicles to mediate transport of the drug to the target organ. In vivo
activity of siRNA delivered to the liver by liposome-based
nanoparticles was first demonstrated in primates where down-
modulation of Apolipoprotein B resulted in significant lowering of
blood cholesterol levels.
7 This study raised further hope for the
application of RNAi therapy to humans although the toxicity of the
delivery vehicle is currently a serious concern for advancement into
the clinic. The short siRNA length of 21 base pairs on one hand
and the complexity of eukaryotic genomes on the other hand limit
the design of target-specific siRNAs with unique binding sites.
Sequence-independent responses like activation of the innate
immune system can largely be circumvented by chemical
modifications.
8 Today, it is still challenging to predict off-target
effects based on computational algorithms since theexact molecular
determinants that direct on- and off-target recognition of
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transcripts are unclear.
9-11 Several studies have shown that target
complementarity to the 7-nucleotide seed region of siRNA
(positions 2–8 from the 5' end on the guide strand) is sufficient
for entry into the RNA-induced silencing complex (RISC) and
subsequent mRNA cleavage and degradation by a microRNA-
like mechanism.
12-14 In order to minimize seed sequence-driven off-
target binding, siRNA design rules have been developed that take
thermodynamic stability, balanced GC content as well as structural
and positional parameters into account.
8 Furthermore understand-
ing oftherules that drivemiRNA bindingtospecific mRNA targets
is likely to improve siRNA target selectivity which is highly
desirable for therapeutic applications in humans.
Here we analyze the off-target activity of two synthetic siRNAs
that target human blood coagulation factor 7 (F7) mRNA in a
panel of human cell lines as model. Based on in silico prediction
these siRNAs, termed F7-1 and F7-2, are devoid of significant
sequence complementarity to any other human transcript. We
applied genome-wide microarray profiling to experimentally
address this prediction and we showed that F7-1 modulates a
significant number of off-target transcripts while F7-2 is virtually
mono-specific for F7. We used the F7-1 off-target CXCL5 as
model system to analyze the mechanism of off-target recognition
by transient transfection of appropriately designed reporter con-
structs. This analysis showed that cooperative binding of F7-1
siRNA to at least two sites with seed sequence similarity is
required to induce off-target activity. Possible relevance of our
findings for the development of RNAi therapeutics is discussed.
Results
On-target activity of F7-1 and F7-2. F7-1 and F7-2 siRNAs
target human blood coagulation factor 7 either in the coding
region or in the 3'-UTR respectively. Both siRNAs were con-
sidered for development of RNAi therapeutics for treatment of
blood clotting disorders. Therefore it is critical to test whether
these molecules have off-target activity although complementa-
rity searches in the human transcriptome did not yield any
significant hits. Here we use a panel of human cell lines under
various experimental conditions to investigate the specificity of
both siRNAs. To validate the experimental system, we transfected
the human hepatoma cell line Hep3B with F7-1 or F7-2 and
measured knock-down of factor 7 mRNA at various time points
after transfection (Fig.1A) or by applying a concentration range
from 10 nM to 250 nM (Fig.1B). Both siRNAs show com-
parable on-target knock-down activity between 75% (F7-2) and
85% (F7-1) 24 h after transfection at a concentration of 10 nM
(Fig.1A). Both siRNAs show maximal knock-down activity at
50 nM and further increase beyond this point had no significant
effect (Fig.1B).
Off-target activity of F7-1 and F7-2. We next analyzed
whether target knock-down of F7 mRNA by F7-1 or F7-2 targets
additional transcripts. We repeated the time course experiment
shown above and analyzed the responses to F7-1 and F7-2
using whole-genome transcript imaging together with green-
fluorescence protein (GFP) or luciferase (Luc) siRNA as
non-targeting controls in Hep3B cells (Fig.2). We applied a
fold-change of 2 (FC . 2o rF C, -2) and a p value , 0.05 as
parameters to call off-target genes for each experimental
condition. Twenty-four hours after transfection F7-1 yields
34 transcripts fulfilling our selection criteria and this set of
genes is only marginally modulated by F7-2 or by established
controls targeting GFP and luciferase (Fig.2A).
11 At 40 h the
expression of 83 genes is affected by F7-1 and the number
of modulated off-target genes declines after 48 h to levels
similar to the 24 h time point. In contrast to F7-1, F7-2 siRNA
modulates significantly fewer transcripts with a maximum of
11 genes at 40 h and only two genes are affected 48 h after
transfection (Fig.2B). As expected, the genuine target F7 is
down-modulated under F7-1 and F7-2 conditions with similar
efficiency.
Figure1. Time- and concentration-dependent knock-down of F7 mRNA by F7–1 and F7–2 siRNA in Hep3B cells. (A) Cells were transfected with each
siRNA at 10 nM and knock-down efficiency was measured followed 24h, 40h and 48h incubation relative to mRNA levels of lipofectamine transfected
cells set to 100%. (B) Cells were transfected with increasing amounts of siRNA and F7 knock-down was measured 24 h after transfection with
lipofectamine transfected cells as reference. All quantifications were performed with a commercial branched-DNA assay (Panomics). For details see
Materials and Methods.
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siRNA concentration-dependent off-target activity. We next
asked whether an increase in the siRNA concentration far above
effective levels would raise the number of co-modulated trans-
cripts. From DNA gel blotting experiments it has long been
known that an excess of probe leads to unspecific hybridization
and high background. Related to RNAi, overloading of the intra-
cellular RISC machinery with exogenous siRNAs could relax the
control of gene expression by the miRNA system resulting in
upregulation of genes that are normally repressed by miRNAs.
15
We transfected Hep3B cells for 24 h with the same set of
siRNAs used above (F7-1, F7-2, GFP and Luc) at 10 nM, 50 nM,
100 nM and 250 nM. For F7-1 the number of down-modulated
genes remained in the same order of magnitude across the entire
concentration range (Fig.3A) while F7-2 has only marginal off-
target activity (Fig.3B). At high F7-1 concentration (250 nM)
about 30 genes are significantly upregulated. The same set is
modulated to some extent by F7-2, GFP or luciferase siRNAs.
Based on the intracellular RISC machinery overloading model,
15
we would expect significant upregulation of numerous genes by
F7-2 which was not the case. Hence, the induction of mRNA
expression is at least partially related to the F7-1 siRNA sequence.
Off-target activity of F7-1 in other cell lines. The RNAi host
defense mechanism is considered ubiquitous and operates in
virtually all vertebrate tissues and cell lines. We tested whether
host cell specific factors such as miRNA content influence off-
target activity of siRNA. In addition to our standard cell line
Hep3B, we transfected the human hepatoma cell
lines HepG2 and Huh-7 together with the human
kidney cell lines G-401 and HEK293 with F7-1 for
24 h at 10 nM followed by microarray-based off-
target analysis as above. In addition, we included
the rat liver cell lines BRL3A and NRL for the
assessment of species restriction of RNAi as shown
by Burchard et al.
16 We used the gene panel modu-
lated by F7-1 in Hep3B as reference (fold-change .
1.5 or \ , -1.5 and p value , 0.05) and retrieved
the corresponding expression data from the other
cell lines. Based on this comparison, virtually all
genes that are downregulated in Hep3B are also
modulated in at least one of the added cell lines,
provided the transcript is expressed (Fig.4; left
panel). In the rat cell lines only a small portion
(, 10) of the human F7-1 off-target orthologs
is down-modulated (Fig.4; right panel) which is
consistent with species restriction of RNAi.
16
Enrichment analysis of seed region matches in
F7-1 off-target genes. The microarray-based off-
target analysis suggests a sequence-dependent mech-
anism of transcript recognition by F7-1 since a
BLAST-based search of all known human transcripts
with both full-length sequences of F7-1 and F7-2 did
not generate any significant matches. Therefore, we
had to consider the possibility that seed sequence
similarity to F7-1 (5'-end positions 2–8 of the anti-
sense guide strand) triggers recognition and sub-
sequent down-modulation of off-target transcripts.
14
To address this possibility, we performed a word
enrichment analysis based on the Sylamer program
which was originally developed for the in silico
detection of potential miRNA targets.
17 We scanned
the 3'-UTRs of all 20,000 transcripts detected by
the microarray under all conditions (time, dose and
cell type) for enrichment of unique heptamer motifs
after purging repetitive stretches and poly-A tails
from the database entries. According to van Dongen
et al., a word becomes significant when the log10
(enrichment p value) is higher than 8. The most
over-represented word fulfilling these criteria across
the entire data set is the reverse complement of the
Figure2. Time-dependent induction of off-target effects by F7-1 (A) and F7-2 (B)
siRNAs in Hep3B cells measured by genome wide microarray profiling. Hep3B cells
were transfected with F7-1, F7-2, GFP or luciferase siRNA at 10 nM for the time points
indicated above the heatmaps. (A) shows transcripts modulated by F7-1 and the fold
change of the same set of transcripts is shown in cells transfected with F7-2, GFP or
luciferase siRNA to illustrate specificity for F7-1. (B) shows the equivalent data for F7-2.
Expression fold change is displayed as a color gradient from blue (downregulation) to
red (upregulation) as indicated by the reference bar. Each line in the heatmap display
corresponds to a gene and gene symbols were omitted for clarity. Red asterisk in the
heatmap indicate expression levels of F7 for the different conditions while green
asterisk indicate expression levels of CXCL5.
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F7-1 seed region 5' CCTATTC 3', followed by the single
mismatch version 5' CCTGTTC 3' (Fig.5; A, time course; B,
concentration; C, human cell lines). Strikingly, significant
enrichment of the single mismatch version of 5' CCTATTC 3'
occurred specifically in the 3'-UTRs of the most downregulated
F7-1 off-target transcripts. This finding suggests that even
imperfect matching to the siRNA seed region can be sufficient
for off-target recognition and entry into the RISC pathway. This
result further supports our previous notion that target recognition
by F7-1 is sequence driven and we consider perfect or imperfect
seed region similarity as a pre-requisite for off-target recognition.
As control, we scanned the 5'-UTRs of the same gene set for
heptamer enrichment which did not yield any significant enrich-
ment data. Furthermore, the ‘Sylamer’ analysis reveals that more
than half of the down-modulated transcripts have multiple perfect
or partial F7-1 seed region matches. A positive correlation
between the number of seed sequence matches in the 3'-UTR
and siRNA silencing potency has been shown by others.
14 We
therefore sorted all F7-1 off-target transcripts according to seed
sequence frequency but could not confirm the reported asso-
ciation between seed region frequency and knock-down efficiency
in our data set.
14 The adenylate kinase 4 (AK4) transcript for
instance contains 11 imperfect copies of the F7-1 seed motif in
the 3'-UTR and yet it is only moderately down-modulated by
F7-1 (data not shown). Interestingly, the F7-1 seed motif was
not recovered in any of the genes that are upregulated at high
siRNA concentrations or prolonged exposure (Figs.2 and 3)
suggesting an RNAi-independent mechanism. In addition, micro-
array profiling can only detect changes in transcript abundance
and changes of protein abundance caused by translational
inhibition require proteomic approaches.
18
Seed sequence enrichment in siRNAs targeting the gluco-
corticoid receptor. To further support the conclusions drawn
above, we assessed the off-target activity of two additional siRNAs
(GCR-1 and GCR-2) targeting the human glucocorticoid
receptor (GR). Both siRNAs were considered as candidates for
clinical development because they had the lowest number of
predicted off-targets in the human transcriptome based on in
silico screening. Similar to F7, GCR-1 targets the coding region
and GCR-2 the 3'-UTR of the glucocorticoid receptor trans-
cript. To keep the study in a manageable scope we performed
transcript profiling at a concentration of 10 nM for 24 h followed
by transcript profiling and ‘Sylamer’ analysis as above. To avoid
mRNA target modulation by GR signaling we have chosen
Hep3B cells for the analysis because these cells do not express the
glucocorticoid receptor. Under these conditions, complement
factor B (CFB) was the only GCR-1 off-target gene (data not
shown) while GCR-2 targeted a total of 38 genes fulfilling our
Figure3. siRNA concentration-dependent induction of off-target effects by F7–1 (A) and F7–2 (B) siRNA in Hep3B cells measured by genome wide
microarray profiling after 24h treatment. For details see legend of Figure2.
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selection criteria (Fig.S1, A). We used all transcripts detected
in the data set for GCR-1 and GCR-2 for a heptamer motif
enrichment analysis using the Sylamer algorithm as above. No
significant motif was enriched in the GCR-1 data set (Fig.S1, B)
while significant enrichment of the reverse complement of
the GCR-2 seed region (5' ATATAGA 3') occurred in genes
down-modulated by GCR-2 (Fig.1C). We conclude that
seed sequence homology is required for entry into the RISC
mediated RNAi pathway.
Mechanism of F7-1 mediated off-target recognition of
CXCL5 transcripts. Next we analyzed the requirement for seed
sequence based off-target recognition. In particular, we tested
whether binding of siRNA to multiple sites in the 3'-UTR as
suggested by Lin et al.
14 is necessary or whether binding of F7-1
to a single site is sufficient for target knock-down. We chose
the chemokine gene CXCL5 as model because it is consistently
silenced by F7-1 under all experimental conditions and the
microarray data were confirmed using branched-DNA assay (data
not shown; Figs.2 and 3). In addition, CXCL5 3'-UTR region
contains five evenly spaced seed motifs (named A, B, C, D and E)
which allows experimental dissection of the role of each heptamer
motif by mutagenesis (Fig.6). To identify the target sites of F7–1
experimentally we employed the commercial pMIR-REPORT
luciferase reporter gene system originally designed to detect short
miRNA target sites in 3'-UTRs. We cloned the full-length cDNA
of CXCL5 transcript (2,460 base pairs) into pMIR-REPORT
(clone 4) and three truncated versions lacking sites C, D and
E( Fig.6A). These constructs were transfected into CXCL5
negative HEK293 cells, together with F7-1 (10 nM, 24 h) and the
β-galactosidase signal normalization vector. Using this assay, only
clone 4 showed significant inhibition (Fig.6B) suggesting that
the heptamer sites C, D and E in the CXCL5 transcript are
preferred targets of F7-1. It further implies that single mismatches
are tolerated in the process of mRNA target recognition.
To further dissect the roles of binding sites C, D and E we
generated additional reporter constructs containing the C, D
and E seed region complement sites including 25 nucleotides
upstream of the predicted binding motif. In addition to monomer
constructs, we also assembled clones containing all possible
dimer configurations and a single construct combing all three
binding sites. The resulting plasmids were co-transfected into
HEK293 cells together with F7-1 and the β-galactosidase
normalization plasmid. None of the monomer sub-clones C
(green), D (orange) or E (black) responded to F7-1 while the
dimers responded in the order C-D, D-E and C-E (Fig.6B). The
triple construct C-D-E showed inhibition in the range of C-D.
These results provide first experimental evidence that a single
mismatch in a discontinuous stretch of the seed sequence is
tolerated to trigger RNAi as suggested based on isothermal
titration calorimetry of siRNA/RISC complexes.
19 The functional
dissection of the F7-1 binding sites suggests that off-target acti-
vity of siRNA requires annealing to at least two seed complement
sites on the target strand.
Discussion
We have analyzed the off-target activity of a pair of siRNAs
(F7-1 and F7-2) that target human blood coagulation factor 7
with high efficiency. We used microarray profiling to detect
co-regulated genes under various experimental conditions and
in multiple cell lines. Based on this analysis, F7-1 suppresses
about 40 off-target transcripts greater than 2-fold while F7-2 is
Figure4. Detection of F7-1 off-target transcripts in additional human
and rat cell lines. The human hepatoma cell lines Hep3B, HepG2 and
Huh-7 and the human kidney lines G-401 and HEK293 were transfected
with 10 nM F7-1 siRNA for 24 h followed by transcript profiling. In
addition, the rat cell lines BRL3A and NRL cells were included to
demonstrate species specificity of siRNA off-target effects. Analogous to
the experiments shown in Figures2 and 3, the transcripts modulated by
F7-1 in Hep3B cells were used as reference and the fold change-factor of
these genes in the other cell lines is shown in a gradient from blue
(downregulation) to red (upregulation) as in Figures2 and 3. For the rat
cell lines the fold change of the human orthologs present on the rat
array is shown. Note that virtually all genes modulated in Hep3B are
found in at least one of the other human lines with exception of the
upregulated genes.
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essentially mono-specific for its target. All transcripts targeted by
F7-1 contain between one and 11 heptamer motifs complement-
ary to the seed region of F7-1 with single base mismatches rang-
ing from 1 to 10 occurrences. Seed sequence enrichment in
off-target transcripts was confirmed independently for GCR-2
which targets the glucocorticoid receptor and has similar off-
target activity as F7-1. Using the chemokine gene CXCL5 as
an off-target model, we have identified by transient transfection
of reporter gene constructs three preferred target sites for F7-1
in the 3'-UTR. Recognition of at least two of these sites is
required for F7-1 off-target activity in our experimental model.
F7-1 and F7-2 were considered as candidates for the develop-
ment of RNAi based therapeutics. The sequences of both con-
structs have no significant matches in the human transcriptome
based on refined BLAST searches (Pamela Tan, personal com-
munication). However the experimental assessment of siRNA
specificity showed that F7-1 modulates a significant number of
transcripts under various conditions while F7-2 has negligible
Figure5 (See opposite page). Enrichment analysis of the F7-1 seed region matches in the 3’-UTR sequence of all expressed genes considering all
experimental conditions (A, dose, B, time course, C, human cell lines panel). The ‘Sylamer’ algorithm scans the 3’-UTRs for enrichment of random
heptamer motifs. The reverse complement of the F7-1 seed region (red) is significantly enriched in the panel of modulated genes followed by the single
mismatch version (5’ CCTGTTC 3’; blue) in most conditions. Enrichment of the 5’ CTATTCA 3’ (black) or 5’ CTGTTCA 3’ (green) heptamers was considered
less significant by the program. In the graphic display, the most downregulated genes appear on the left side of the x-axis and induced genes are on the
right side of each window. The curve indicates the frequency of each motif and the statistical cut-off is marked by a dotted line. The log10 of the
enrichment p value is plotted on the y-axis. Motifs without any significant enrichment in either condition are shown in gray.
Figure6. Schematic outline of the CXCL5 cloning strategy used for F7–1 binding site mapping. (A) Clone 4 contains the full-length CXCL5 cDNA sequence
without poly-A tail. Clones 1–3 represent truncated versions of CXCL5 sequence containing seed motifs A–E with the exact positions indicated in
brackets. The coding region of CXCL5 is shown as a gray box. (B) Detection of F7-1 predicted binding sites in CXCL5 cDNA clones by reporter gene assays.
The CXCL5 pMIR_REPORT sub-clones 1–4 were transiently co-transfected into HEK293 cells with siRNA and b-galactosidase plasmid for calibration.
The data represent the average of three independent experiments with three biological replicates each.
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off-target activity (Figs. 2 and 3). Based on transcriptional
responses in HepG2 cells that do not express F7 we can eliminate
the possibility that off-target modulation is a response to F7
depletion: the number of transcripts down-modulated by F7-1
was in the same order of magnitude as in Hep3B.
Several groups have shown independently that 7-nucleotide
seed region sequence complementarily is sufficient for RISC
binding and mRNA knock-down.
12-14;20 This provides a plausible
explanation why none the off-targets found experimentally was
detected in silico. The word enrichment analysis further supports
seed sequence-mediated target recognition because all genes
affected by F7-1 or GCR-2 contain perfect or partial matches
to the reverse complement of the siRNA seed region with no
obvious preference for the CDS or 3'-UTR. Likewise, we detected
seed sequence matches in all genes down-modulated by F7-2
siRNA (data not shown). In at least half of the F7-1 affected genes
we found multiple copies of the seed heptamer motifs but we
could not demonstrate a positive correlation between the
prevalence of the seed motifs and knock-down efficiency as
shown by Lin et al.
14 Furthermore, we failed to detect any
heptamer sequence enrichment in the genes upregulated by F7-1
indicating a seed sequence independent mechanism. We also
considered the possibility that a miRNA controlling expression of
the upregulated genes was down-modulated by F7-1 which
cannot be detected mRNA microarrays. However, according to
the TARbase5.0 database not a single gene of the upregulated set
is a validated miRNA target. Overloading of the intracellular
RISC machinery by transfected siRNA at high concentration
was suggested as an alternative mechanism to activate expression
of genes normally silenced by miRNAs.
15 According to this
model, we would also expect upregulation of genes in the F7-2
transfection experiments at high concentration or prolonged
siRNA exposure which was not the case.
The CXCL5 transfection experiments demonstrate a direct
role of the heptamer seed motifs in gene silencing by F7-1
together with the tolerance for single mismatches provided that
cooperative binding to two sites occurs. However, not all available
motifs are recognized and it is currently unclear which factors
drive targeting of three out of five motifs in the CXCL5 sequence
by F7-1. The regular spacing of about 300 nucleotides between
the individual binding sites rules out preferred binding to the
C-D-E sites due to steric hindrance. In addition, these sites are
recognized and active in the synthetic dimer and trimer constructs
where spacing is reduced to about 30 nucleotides. The close
proximity of the sites in the recombinant constructs eliminates
to a large extent a prominent role of RNA folding and other
structural features of the native transcript. All F7-1 target sites
contain single base mismatches at different positions. This could
lead to site preference and cooperative binding since the mismatch
position can impact heteroduplex stability between the siRNA
seed region and the target mRNA.
19 In fact, the mismatch
position is at the 5' end in C, centered in D and 3' in E (Fig.6).
Maximal knock-down activity in the range of clone 4 requires
binding of F7-1 to the D site in conjunction with the C site
located upstream of D. Cooperative binding to D and E induces
only partial knock-down and the presence of all sites results in the
triple construct displays similar activity like the C-D pair
and clone 4. We noted that the mismatch of the critical D site
is G:U and it has been shown that this wobble mismatch leads
to formation of a stable RNA duplex.
19 When G:U is located at
position 4 or 5 of the seed region, as in D, RISC loading is
efficient and only marginally reduced compared with a perfect
match control.
19 In contrast, the mismatch in the C and E sites
is located at terminal positions 7 or 2 of F7-1 seed region
respectively. This configuration leads to substantial reduction of
target affinity and RISC loading.
19 In addition, the C and E sites
flank the dominant D site which may further favor cooperative
binding and recognition of these binding sites in CXCL5.
21;22
Thus, we propose that binding of F7-1 to the dominant D site
transforms the target mRNA into a stable state which enables
cooperative binding to the C or E sites. We consider RNA folding
and secondary structure as less important since the native CXCL5
mRNA and the mono-cistronic, artificial transcript generated
by pMIR-REPORT luciferase vector exhibit comparable knock-
down activity despite different sequence context. At this point
it is unclear why the A and B sites are not targeted by F7-1. The
mismatch nucleotide in site A is at the favorable position 5 of
F7-1 seed region which leads to formation of a stable hetero-
duplex. However, localization of this site in the coding sequence
of CXCL5 might disable F7-1 binding (Fig.6). The mismatch in
B occurs at position 7 of F7-1 seed region and this localization is
likely to reduce the binding affinity of F7-1. The considerations
above suggest that the position of the mismatch in the heptamer
target site of F7-1 siRNA is a major determinant for preferred
recognition in our F7-1/CXCL5 model system. Finally, the partial
usage of seed sites in our model may explain the lack of correla-
tion between knock-down efficiency and seed motif prevalence
in our studies. The requirement for at least two seed sequence
motifs in a favorable configuration may explain the on-target
specificity of F7-2 and the lack of off-target effects for the GFP and
luciferase controls. The occurrence of multiple seed matches in all
down-modulated F7-1 off-target transcripts supports this view.
Experimental RNAi in cell lines and animal models has
become an indispensable tool for drug target validation and other
biomedical applications in the last decade. Currently, ongoing
pharmaceutical research explores RNAi as a novel therapeutic
modality due to the fascinating opportunity of targeting any
transcript.
23 Advancement in this field is currently limited by the
lack of efficient and safe delivery vehicles and the inability to
design mono-specific siRNAs to avoid off-target activity. The
short length of the seed sequence in the siRNA guide strand
together with the high prevalence of heptamer motifs in any
genome make the design of mono-specific siRNA highly challeng-
ing. The seed region motifs of F7-1 (5' CCTATTC 3') and F7-2
(5' CTTCGAT 3') for instance have 3,260 or 1,320 hits in all
RefSeq annotated transcripts and randomly generated heptamer
sequences occur at frequencies ranging from 1,200 to 3,700 hits
in the RefSeq database. Therefore, we consider experimental off-
target detection in human cell lines currently as a favorable
approach to assess off-target activity of siRNAs. The high on-
target specificity of F7-2 proves that it should be possible to
design siRNAs with a favorable off-target profile. A recent report
24
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describes a new 2-stage algorithm termed SVMicrO for the
prediction of miRNA targets based on training of support vector
machine with data available in miRecords or with data from
published microarray experiments. Once the rules for accurate
target recognition by miRNAs are understood, these principles
may be translated to siRNA design since the RISC processing
pathway is shared.
Currently, new generations of siRNAs are under development
aimed at reducing the off-target activity seen in standard ribo-
nucleotide constructs. Asymmetric siRNAs for instance contain a
full-length antisense strand and a truncated passenger strand
which results in a significant reduction of off-target activity.
25
Another strategy employs the replacement of the RNA seed region
by DNA which diminishes thermodynamic stability of duplexes
with single nucleotide mismatches of the DNA seed region
binding and the RNA target.
26 An alternative, is perhaps the use
of antisense oligonucleotides as drugs which is currently revisited
because their stability and specificity have undergone significant
improvements in the last decade.
27 At the time of writing, 35
clinical studies with antisense nucleotides are ongoing compared
with five phase 1 studies with siRNA. Target recognition of
antisense oligonucleotides depends solely on proper Watson and
Crick base-pairing to the target which is entirely RISC-
independent. Consequently, off-target effects due to seed
sequence matches are not an issue, implying that design of
mono-specific oligonucleotides is less problematic.
In summary, our study further reduces the stringency for
primary sequence based off-target recognition. Further studies
are necessary to show general validity of our conclusions for other
siRNAs with off-target activity. Based on the high statistical
occurrence of heptamer motifs in nucleic acids it is obvious to
postulate existence of additional rules and mechanisms contrib-
uting to naturally occurring target specificity of miRNAs. Based
on our current knowledge it remains challenging to design highly
mono-specific siRNAs such as F7-2 using in silico prediction
algorithms.
Materials and Methods
siRNA constructs. Two siRNAs, named F7-1 and F7-2 siRNA,
were designed to target human blood coagulation factor 7 (F7).
F7-1 siRNA (5' ATGTGGAAAA ATACCTATTC T 3') targets
the coding region of F7 mRNA whereas F7-2 siRNA (5'
GATATGCACA CACACGGATG C 3') targets the 3'-UTR. As
a control for gene expression microarray experiments two addi-
tional non-targeting siRNAs were used; the green-fluorescence
protein, GFP (5' CCACATGAAG CAGCACGACT T 3') and
the firefly luciferase, Luc (5' CTTACGCTGA GTACTTCGAT
T 3'). GCR-1 (5' TGGTCGAACA GTTTTTTCTdT dT 3')
and GCR-2 (5' TGCTTAACTA CATATAGATdT dT 3')
siRNAs were designed to target the coding region and the 3'-
UTR of the human glucocorticoid receptor respectively.
Cell culture, siRNA transfection and RNA isolation. Cell
lines were obtained from Roche Non-Clinical Biorepository
group. They were cultured under standard conditions (37°C, 5%
CO2) with the following media: DMEM with 4.5 g/L glucose
(Invitrogen, 41965–039) and 10% FBS for Huh-7, EMEM with
GlutaMAX-I (Invitrogen, 41090–028) and 10% FBS for HepG2
and Hep3B, McCoy’s 5A medium with L-Glutamine (Invitrogen,
26600–023) and 10% FBS for G-401, DMEM (Invitrogen,
41090–028) with 10% FBS for HEK293 and Ham’s F12
(Invitrogen, 21127–022) with 10% FBS for BRL3A and NRL.
Hep3B and Huh-7 cell lines express F7 while the other cell lines
do not. Two hundred fifty thousand cells per well were seeded in
a 6-well plate 14 h before transfection. The cells were transfected
with 10 nM, 50 nM, 100 nM or 250 nM siRNA using Lipofect-
amine
TM 2000 reagent (Invitrogen, 11668–019). Each transfec-
tion was performed in triplicate and the cells were harvested with
1 mL of TRIzol reagent (Invitrogen, 15596–026) 24 h, 40 h or
48 h after transfection. Total RNA isolation was performed using
Invitrogen’s standard protocol. RNA quality was assessed by
agarose gel electrophoresis and quantification was performed using
the RiboGreen
1 RNA quantitation kit (Invitrogen, R-11490).
Quantigene branched-DNA assay. Quantification of F7 and
CXCL5 mRNAs was performed using QuantiGene2.0 branched-
DNA assay (b-DNA) from Panomics (QS0008). Total RNA was
isolated from siRNA-treated cells and hybridized to specific
b-DNA probes according to the manufacturer’s instructions
and raw data were collected by measuring luminescence in a
microplate reader (Victor
3 multilabel counter, Perkin Elmer).
Data were normalized by calculating the ratio between the signal
intensity of the target mRNA and the signal intensity of the
housekeeping gene GAPDH.
Microarray experiments and gene expression data analysis.
Gene expression microarray experiments were conducted on
HumanWG-6.V3 (BD101–0603, 48,804 probes derived from
human genes in the NCBI RefSeq and UniGene databases)
and RatRef-12.V1 (BD27–302, 22,519 probes derived from rat
genes in the NCBI RefSeq and UniGene databases) Illumina
Beadchips. 500 ng of total RNA was amplified and biotinylated
using the TotalPrep RNA amplification kit (Ambion, AMIL1791).
For each sample, 1,500 ng or 750 ng of labeled cRNAs were
hybridized onto human or rat beadchips, respectively, using the
Illumina whole genome gene expression direct hybridization
protocol. The beadchips were scanned using Illumina iScan and
the raw data were generated by GenomeScan software (Illumina).
The raw data were then log2 transformed and quantile normalized
without background subtraction. ANOVA statistical tests were
performed in order to calculate samples’ p value and fold-change,
the fold-change being a number describing how much the
expression value of a gene changes upon treatment. Pairwise
comparisons were performed between the treated samples and the
control and changes were considered significant for fold-change
. 2o r, -2 and a p value , 0.05.
Word enrichment analysis. mRNA sequences were retrieved
from the RefSeq database
28 and only 3'-UTR regions were
included in the analysis. Redundant sequences were masked using
the RSAT algorithm.
29 Finally, the poly-A tails were removed
from the 3'-end. Sequences were sorted by ascending experi-
mental fold-change. Enrichment or depletion for 7-nucleotide
word in this ranked gene list was analyzed using the ‘Sylamer’
program.
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Cloning and plasmid/siRNA co-transfection. Full-length and
truncated cDNA fragments of CXCL5 were amplified from
Hep3B total RNA using Titan One Tube RT-PCR System kit
(Roche, 11939823001) using a common 5'-end primer (5'
GGCGTTTAAA CCGCAGCGCT CTCTTGACCA CT 3')
and truncation-specific 3'-end primers (clone 1: 5' GCGGTT-
TAAA CTTCCATGCG TGCTCATTTC TC 3'; clone 2: 5'
CGGGTTTAAA CATTCTACAT AGATAAGGTG TG 3';
clone 3: 5' CGGGTTTAAA CTCAGGAATT TGCCTGT-
TTT C 3'; clone 4: 5' CGGGTTTAAA C GTTTAAACTT
TTTTTTTTTT TTTTTTGA 3') (Fig.6). The corresponding
PCR products were cloned into pCR2.1-TOPO vector (Invitro-
gen, K4500–40) and after sequence verification cDNA frag-
ments were then sub-cloned into the unique PmeI site of the
commercial vector pMIR_REPORT luciferase (Apply Biosystems,
AM5795). The resulting clones were referred as clone 4 for the
full-length sequence and clones 1–3 for the truncated sequences
(Fig.6). The sequences corresponding to the F7-1 target sites C,
D, E, the dimer constructs C-D, C-E or D-E and the trimer
construct C-D-E were chemically synthesized and sub-cloned into
pMIR_REPORT Luciferase vector in a 5'-3' orientation using
SpeI (5' end) and HindIII (3' end) overhangs (TableS1). ApaI
restriction site was used for clone screening.
Dual-light luciferase assay. We used the Dual-light
1 system
from Applied Biosystems (T1005) as readout for transcript
regulation after 10 nM F7–1, CXCL5 and luciferase siRNA
treatment. Luciferase siRNA from Microsynth (5' CaaCACC-
CCA ACAUCUUCGTT 3') and CXCL5 siRNA from
Dharmacon (5' CCGCUGCUGU GUUGAGAGA 3') target
respectively the coding region of the firefly luciferase and
CXCL5. 0.045 ng/mL of pMIR_REPORT luciferase vector was
co-transfected with 0.01 ng/mLo fβ-galactosidase control vector
into HEK293 cells in order to normalize the luciferase signal
intensity across the samples. Firefly luciferase and β-galactosidase
signal intensity was measured using a microplate reader com-
bined with a dispenser (Victor
3 multilabel counter, Perkin
Elmer).
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